A detailed history of Simplex Trading, LLC transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 5,022 shares of AVTE stock, worth $12,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,022
Previous 5,853 14.2%
Holding current value
$12,856
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$1.61 - $2.09 $1,337 - $1,736
-831 Reduced 14.2%
5,022 $10,000
Q2 2024

Jul 25, 2024

BUY
$1.41 - $30.75 $8,252 - $179,979
5,853 New
5,853 $9,000

Others Institutions Holding AVTE

About Aerovate Therapeutics, Inc.


  • Ticker AVTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,448,100
  • Market Cap $62.6M
  • Description
  • Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...
More about AVTE
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.